Skip to main content
Clinical Trials/NL-OMON55558
NL-OMON55558
Recruiting
Not Applicable

on-invasive diagnosis and treatment of neonatal jaundice in primary care - STARSHIP

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
5500
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Babies are eligible if:
  • \- They were born after 35 completed weeks of gestation.
  • \- They are admitted in a participating PCBC during the study period within the
  • first week of life.
  • \- They are expected to remain admitted for at least two days (so as to allow
  • for serial TcB measurements to take place).
  • \- Signed informed consent (IC) is available from parent(s)

Exclusion Criteria

  • Babies are not eligible if:
  • \- They previously received phototherapy (reliability of TcB measurement is
  • reduced in babies who are receiving or have received phototherapy).
  • \- They have large congenital anomalies at the sternum or forehead.
  • \- Parents do not have sufficient understanding of the Dutch language to be able
  • to comprehend the patient information sheet.

Outcomes

Primary Outcomes

Not specified

Similar Trials